214 related articles for article (PubMed ID: 35918736)
1. IDO/kynurenine pathway in cancer: possible therapeutic approaches.
Abd El-Fattah EE
J Transl Med; 2022 Aug; 20(1):347. PubMed ID: 35918736
[TBL] [Abstract][Full Text] [Related]
2. Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.
Ohta Y; Kubo H; Yashiro K; Ohashi K; Tsuzuki Y; Wada N; Yamamoto Y; Saito K
J Physiol Sci; 2017 May; 67(3):361-372. PubMed ID: 27364617
[TBL] [Abstract][Full Text] [Related]
3. Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment.
Pacheco JHL; Elizondo G
Biochem Pharmacol; 2023 Nov; 217():115804. PubMed ID: 37716620
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine, a Tryptophan Metabolite That Increases with Age, Induces Muscle Atrophy and Lipid Peroxidation.
Kaiser H; Yu K; Pandya C; Mendhe B; Isales CM; McGee-Lawrence ME; Johnson M; Fulzele S; Hamrick MW
Oxid Med Cell Longev; 2019; 2019():9894238. PubMed ID: 31737181
[TBL] [Abstract][Full Text] [Related]
5. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
Nguyen TT; Shin DH; Sohoni S; Singh SK; Rivera-Molina Y; Jiang H; Fan X; Gumin J; Lang FF; Alvarez-Breckenridge C; Godoy-Vitorino F; Zhu L; Zheng WJ; Zhai L; Ladomersky E; Lauing KL; Alonso MM; Wainwright DA; Gomez-Manzano C; Fueyo J
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35902132
[TBL] [Abstract][Full Text] [Related]
6. Inflammation-Induced Tryptophan Breakdown is Related With Anemia, Fatigue, and Depression in Cancer.
Lanser L; Kink P; Egger EM; Willenbacher W; Fuchs D; Weiss G; Kurz K
Front Immunol; 2020; 11():249. PubMed ID: 32153576
[TBL] [Abstract][Full Text] [Related]
7. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
Lemos H; Mohamed E; Ou R; McCardle C; Zheng X; McGuire K; Homer NZM; Mole DJ; Huang L; Mellor AL
Front Immunol; 2020; 11():1256. PubMed ID: 32625215
[TBL] [Abstract][Full Text] [Related]
8. Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells.
Jonescheit H; Oberg HH; Gonnermann D; Hermes M; Sulaj V; Peters C; Kabelitz D; Wesch D
Cells; 2020 May; 9(5):. PubMed ID: 32384638
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the sEH Inhibitor Epoxykynin as a Potent Kynurenine Pathway Modulator.
Dötsch L; Davies C; Hennes E; Schönfeld J; Kumar A; Guita CDCL; Ehrler JHM; Hiesinger K; Thavam S; Janning P; Sievers S; Knapp S; Proschak E; Ziegler S; Waldmann H
J Med Chem; 2024 Mar; 67(6):4691-4706. PubMed ID: 38470246
[TBL] [Abstract][Full Text] [Related]
10. IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy.
Park J; Nah Y; Kim WJ
J Control Release; 2023 Nov; 363():496-506. PubMed ID: 37788761
[TBL] [Abstract][Full Text] [Related]
11. The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.
Wang Y; Hu GF; Wang ZH
Onco Targets Ther; 2017; 10():3557-3566. PubMed ID: 28790848
[TBL] [Abstract][Full Text] [Related]
12. Photothermal-Enhanced Dual Inhibition of Lactate/Kynurenine Metabolism for Promoting Tumor Immunotherapy.
Xie Y; Wang M; Qiao L; Qian Y; Xu W; Sun Q; Luo S; Li C
Small Methods; 2024 Mar; 8(3):e2300945. PubMed ID: 37906051
[TBL] [Abstract][Full Text] [Related]
13. Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer.
Wyatt M; Greathouse KL
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33916690
[TBL] [Abstract][Full Text] [Related]
14. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis.
Wirthgen E; Hoeflich A
J Amino Acids; 2015; 2015():973548. PubMed ID: 26881062
[TBL] [Abstract][Full Text] [Related]
16. The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer.
León-Letelier RA; Dou R; Vykoukal J; Sater AHA; Ostrin E; Hanash S; Fahrmann JF
Front Oncol; 2023; 13():1256769. PubMed ID: 37876966
[TBL] [Abstract][Full Text] [Related]
17. The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells.
Soltani-Asl M; Azimnasab-Sorkhabi P; Yoshinaga TT; de Oliveira Massoco C; Kfoury JR
Immunol Res; 2023 Dec; ():. PubMed ID: 38153625
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan and Its Metabolites in Lung Cancer: Basic Functions and Clinical Significance.
Li C; Zhao H
Front Oncol; 2021; 11():707277. PubMed ID: 34422661
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Modulation of Kynurenine Based on Kynureninase-Loaded Nanoparticle Depot Overcomes Tumor Immune Evasion in Cancer Immunotherapy.
Chae SY; Shin H; Woo J; Kang S; Lee SM; Min DH
ACS Appl Mater Interfaces; 2024 Apr; 16(15):18490-18502. PubMed ID: 38573937
[TBL] [Abstract][Full Text] [Related]
20. Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzyme.
Blazeck J; Karamitros CS; Ford K; Somody C; Qerqez A; Murray K; Burkholder NT; Marshall N; Sivakumar A; Lu WC; Tan B; Lamb C; Tanno Y; Siddiqui MY; Ashoura N; Coma S; Zhang XM; McGovern K; Kumada Y; Zhang YJ; Manfredi M; Johnson KA; D'Arcy S; Stone E; Georgiou G
Nat Catal; 2022 Oct; 5(10):952-967. PubMed ID: 36465553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
